Fig. 1From: The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trialProtocol of the study. Legend: TAO, thromboangiitis obliterans; SLE, systemic lupus erythematosus; HES, hypereosinophilic syndrome; PBMNCs, peripheral blood mononuclear cells; PCCs, purified CD34+ cellsBack to article page